Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Nuclear Medicine

  Free Subscription


Articles published in Nuklearmedizin

Retrieve available abstracts of 123 articles:
HTML format



Single Articles


    July 2021
  1. LAPA C, Nestle U, Albert NL, Baues C, et al
    Value of PET imaging for radiation therapy.
    Nuklearmedizin. 2021 Jul 14. doi: 10.1055/a-1525-7029.
    PubMed     Abstract available


  2. KREPPEL B, Gonzalez-Carmona MA, Feldmann G, Kuppers J, et al
    Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours.
    Nuklearmedizin. 2021 Jul 13. doi: 10.1055/a-1521-8604.
    PubMed     Abstract available


  3. SAHIN O, Kaya B, Aydin Z, Sen AE, et al
    Prostate incidentaloma on 18F-fluorodeoxyglucose positron emission tomography: Diagnostic value of volumetric positron emission tomography parameters.
    Nuklearmedizin. 2021 Jul 9. doi: 10.1055/a-1525-7607.
    PubMed     Abstract available


    June 2021
  4. OBMANN VC, Grosse-Hokamp N, Alberts I, Fulton N, et al
    Diagnosis and staging of hepatobiliary malignancies: Potential incremental value of (18)F-FDG-PET/MRI compared to MRI of the liver.
    Nuklearmedizin. 2021 Jun 8. doi: 10.1055/a-1486-3671.
    PubMed     Abstract available


  5. HELLWIG D
    Hope for new developments in the reimbursement of oncological PET/CT in Germany.
    Nuklearmedizin. 2021;60:205-208.
    PubMed    


    April 2021
  6. BARENFANGER F, Block A, Schmelz D, Hamami-Arlinghaus M, et al
    Individual calculation of perfusion activity based on ventilation efficiency for V/P-SPECT.
    Nuklearmedizin. 2021 Apr 16. doi: 10.1055/a-1429-1832.
    PubMed     Abstract available


  7. TATOGLU MT, Uslu H, Ibisoglu E
    The value of (18)F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis.
    Nuklearmedizin. 2021 Apr 9. doi: 10.1055/a-1429-2237.
    PubMed    


  8. FREUDENBERG LS, Essler M, Herrmann K
    [Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey].
    Nuklearmedizin. 2021 Apr 1. doi: 10.1055/a-1446-7641.
    PubMed     Abstract available


    March 2021
  9. CHEN YH, Yu MM, Wang ZG
    Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP.
    Nuklearmedizin. 2021 Mar 23. doi: 10.1055/a-1307-1923.
    PubMed     Abstract available


    February 2021
  10. HAPPEL C, Borowski M, Kamp A, Rudolf F, et al
    [Prenatal Radiation Exposure in Nuclear Medicine].
    Nuklearmedizin. 2021 Feb 11. doi: 10.1055/a-1365-7954.
    PubMed     Abstract available


  11. DADGAR H, Norouzbeigi N, Gholamrezanezhad A, Assadi M, et al
    Correction: Incidental Detections Suggestive of COVID-19 in Asymptomatic Patients Undergoing 68Ga-DOTATATE and 68Ga-PSMA-11 PET-CT Scan for Oncological Indications.
    Nuklearmedizin. 2021 Feb 9. doi: 10.1055/a-1379-4070.
    PubMed    


  12. ZIPPEL C, Giesel FL, Kratochwil C, Eiber M, et al
    [PSMA radioligand therapy could pose infrastructural challenges for nuclear medicine: results of a basic calculation for the capacity planning of nuclear medicine beds in the German hospital sector].
    Nuklearmedizin. 2021 Feb 2. doi: 10.1055/a-1351-0030.
    PubMed     Abstract available


  13. WIEDITZ M, Essler M, Luster M
    [Nursing in Nuclear medicine - decisive factor for future Theranostics].
    Nuklearmedizin. 2021;60:5-6.
    PubMed    


    January 2021
  14. MINGELS C, Vollnberg B, Rominger A, Afshar-Oromieh A, et al
    Extended perfusion defects in lung perfusion-SPECT/CT in a case of fatal COVID-19 pneumonia.
    Nuklearmedizin. 2021 Jan 26. doi: 10.1055/a-1333-0226.
    PubMed    


    December 2020
  15. DADGAR H, Norouzbeigi N, Gholamrezanezhad A, Assadi M, et al
    Incidental Detections Suggestive of COVID-19 in Asymptomatic Patients Undergoing 68Ga-DOTATATE and 68Ga-PSMA-11 PET-CT Scan for Oncological Indications.
    Nuklearmedizin. 2020 Dec 16. doi: 10.1055/a-1311-2856.
    PubMed    


  16. LIU H, Liu Y, Chen Y, Liu H, et al
    68Ga-PSMA Uptake in Pulmonary Tuberculosis: A Pitfall in Prostate Cancer PET Imaging.
    Nuklearmedizin. 2020 Dec 10. doi: 10.1055/a-1312-6148.
    PubMed    


  17. ESSLER M, Kreppel B
    [In Reply: Invisible Hand - Re: [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging].
    Nuklearmedizin. 2020;59:456.
    PubMed    


  18. BIERSACK HJ, Ahmadzadehfar H
    Re: [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.
    Nuklearmedizin. 2020;59:455.
    PubMed    


  19. CARRIO I, Essler M, Freudenberg LS, Herrmann K, et al
    "COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty" based on a report of Prof. Dr. Ignasi Carrio.
    Nuklearmedizin. 2020;59:405-408.
    PubMed    


    November 2020
  20. HARTMANN L, Bundschuh L, Zsoter N, Essler M, et al
    Tumor heterogeneity for differentiation between liver tumors and normal liver tissue in 18F-FDG PET/CT.
    Nuklearmedizin. 2020 Nov 3. doi: 10.1055/a-1270-5568.
    PubMed     Abstract available


    October 2020
  21. BUDAK A, Beyan E, Inan AH, Kanmaz AG, et al
    PET Parameters are Useful in Predicting Endometrial Cancer Risk Classes and Prognosis.
    Nuklearmedizin. 2020 Oct 26. doi: 10.1055/a-1267-8976.
    PubMed     Abstract available


  22. BIERMANN M, Kanoun S, Davidsen T, Gray R, et al
    An Open Source Solution for "Hands-on" teaching of PET/CT to Medical Students under the COVID-19 Pandemic.
    Nuklearmedizin. 2020 Oct 26. doi: 10.1055/a-1267-9017.
    PubMed     Abstract available


  23. JUENGLING FD, Allenbach G, Bruehlmeier M, Klaeser B, et al
    Appropriate use criteria for dementia amyloid imaging in Switzerland - mini-review and statement on behalf of the Swiss Society of Nuclear Medicine and the Swiss Memory Clinics.
    Nuklearmedizin. 2020 Oct 20. doi: 10.1055/a-1277-6014.
    PubMed     Abstract available


  24. BEGUM NJ, Glatting G, Eiber M, Beer AJ, et al
    An in silico study on the effect of the radionuclide half-life on PET/CT imaging with PSMA-targeting radioligands.
    Nuklearmedizin. 2020 Oct 16. doi: 10.1055/a-1253-1535.
    PubMed     Abstract available


    September 2020
  25. KURTH J, Uhlander J, Aladwan H, Gohrendt A, et al
    Semi-automated Analysis of Ventilation-Perfusion Single-Photon Emission Tomography in the Diagnosis of Pulmonary Embolism - Does it add extra value?
    Nuklearmedizin. 2020 Sep 29. doi: 10.1055/a-1253-7951.
    PubMed     Abstract available


  26. MOKOALA KMG, Lawal IO, Lengana T, Popoola GO, et al
    18F-FDG PET/CT imaging of vulva cancer recurrence: A comparison of PET-derived metabolic parameters between women with and without HIV infection.
    Nuklearmedizin. 2020 Sep 1. doi: 10.1055/a-1221-7810.
    PubMed     Abstract available


    July 2020
  27. DORAU-RUTKE V, Huang K, Lukas M, Schulze MO, et al
    18F-sodium fluoride bone deposition quantitation with PET in Mice: Variation with age, sex, and circadian rhythm.
    Nuklearmedizin. 2020 Jul 16. doi: 10.1055/a-1205-0082.
    PubMed     Abstract available


    June 2020
  28. SCHLEUPNER MC, Riemann B, Schafers M, Backhaus P, et al
    Impact of FDG-PET on therapy management and outcome of differentiated thyroid carcinoma patients with elevated thyroglobulin despite negative iodine scintigraphy.
    Nuklearmedizin. 2020 Jun 15. doi: 10.1055/a-1177-9728.
    PubMed     Abstract available


    May 2020
  29. KREPPEL B, Gartner FC, Marinova M, Attenberger U, et al
    [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.
    Nuklearmedizin. 2020 May 11. doi: 10.1055/a-1164-5667.
    PubMed    


    April 2020
  30. FREUDENBERG LS, Dittmer U, Herrmann K
    Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020.
    Nuklearmedizin. 2020 Apr 28. doi: 10.1055/a-1163-3096.
    PubMed     Abstract available


  31. LUTJE S, Marinova M, Kutting D, Attenberger U, et al
    Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.
    Nuklearmedizin. 2020 Apr 7. doi: 10.1055/a-1152-2341.
    PubMed     Abstract available


  32. DITTRICH D, Pyka T, Scheidhauer K, Lutje S, et al
    Textural features in FGD-PET/CT can predict outcome in melanoma patients to treatment with Vemurafenib and Ipililumab.
    Nuklearmedizin. 2020 Apr 7. doi: 10.1055/a-1140-5458.
    PubMed     Abstract available


  33. HEINZEL A, Marienhagen J, Yekta-Michael SS, Mottaghy FM, et al
    Pilot study of a newly developed eLearning tool to teach CT and PET/CT in radiology and nuclear medicine.
    Nuklearmedizin. 2020;59:79-84.
    PubMed     Abstract available


  34. KRAUSE BJ, Bartenstein P, Freudenberg LS, Herrmann K, et al

    Nuklearmedizin. 2020;59:e1-e4.
    PubMed    


    March 2020
  35. MENERET P, Girard A, Pagenault M, Riffaud L, et al
    Different manifestations detected with 68Ga-DOTATOC PET/CT in patients with Von Hippel-Lindau disease: A case report.
    Nuklearmedizin. 2020 Mar 19. doi: 10.1055/a-1132-5104.
    PubMed    


  36. FECH V, Sachpekidis C, Alberts I, Rominger A, et al
    Atypical metastatic pattern of prostate cancer detected with 68Ga-PSMA PET/CT.
    Nuklearmedizin. 2020 Mar 18. doi: 10.1055/a-1108-1275.
    PubMed    


  37. KOTZERKE J, Fetzer P, Grosche-Schlee S, Hanel A, et al
    [Development of a system for risk analysis in treatment with unsealed radioactive substances in nuclear medicine].
    Nuklearmedizin. 2020 Mar 3. doi: 10.1055/a-1119-0849.
    PubMed     Abstract available


    February 2020
  38. CEGLA P, Burchardt E, Cholewinski W, Gwozdz S, et al
    Comparison of semiquantitative metabolic parameters of the primary tumor obtained in PET/CT with 18F-FDG and 18F-FLT in patients with cervical cancer.
    Nuklearmedizin. 2020 Feb 25. doi: 10.1055/a-1084-4766.
    PubMed     Abstract available


  39. BUDAK E, Yanarates A
    PET/CT Parameters are Useful in Discrimination of Incidental Benign, Premalignant and Malignant Colonic Lesions.
    Nuklearmedizin. 2020 Feb 24. doi: 10.1055/a-1084-4723.
    PubMed     Abstract available


  40. DIETLEIN M, Klussmann JP, Drzezga A
    [18F-FDG PET/CT in head and neck tumors].
    Nuklearmedizin. 2020;59:8-11.
    PubMed    


  41. LUSTER M
    [Back to the Future - Chances and Challenges for Nuclear Medicine].
    Nuklearmedizin. 2020;59:6-7.
    PubMed    


    January 2020
  42. BIALEK EJ, Malkowski B
    Is the level of diffusion restriction in celiac and cervico-thoracic sympathetic ganglia helpful in their proper recognition on PSMA ligand PET/MR?
    Nuklearmedizin. 2020 Jan 31. doi: 10.1055/a-1079-3855.
    PubMed     Abstract available


    December 2019
  43. KUHNEL C, Seifert P, Mulik C, Winkens T, et al
    3D printing of fillable individual thyroid replicas based on nuclear medicine DICOM data used as phantoms for gamma probe calibration.
    Nuklearmedizin. 2019 Dec 19. doi: 10.1055/a-1070-9874.
    PubMed     Abstract available


  44. BURCHERT W, Hugenberg V
    [The Gordian Knot 2.0 - Decentralized production of radiopharmaceuticals].
    Nuklearmedizin. 2019;58:420-423.
    PubMed    


    November 2019
  45. ALBERTS I, Sachpekidis C, Fech V, Rominger A, et al
    PSMA-negative prostate cancer and the continued value of choline-PET/CT.
    Nuklearmedizin. 2019 Nov 25. doi: 10.1055/a-1044-1855.
    PubMed    


  46. WUNDERLICH G, Freudenberg R, Hartmann H, Herrling P, et al
    [Radiation Exposition of preparations of radiopharmaceuticals in routinely use, measured with optical-stimulated luminescence (OSL) dosimeters].
    Nuklearmedizin. 2019 Nov 13. doi: 10.1055/a-1031-9251.
    PubMed     Abstract available


  47. MICHALSKI K, Mix M, Meyer PT, Ruf J, et al
    Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy.
    Nuklearmedizin. 2019 Nov 13. doi: 10.1055/a-1035-9052.
    PubMed     Abstract available


  48. WINKENS T, Seifert P, Hollenbach C, Kuhnel C, et al
    The FUSION iENA Study: Comparison of I-124-PET/US Fusion Imaging with Conventional Diagnostics for the Functional Assessment of Thyroid Nodules by Multiple Observers.
    Nuklearmedizin. 2019 Nov 11. doi: 10.1055/a-1031-9832.
    PubMed     Abstract available


  49. WEISSINGER M, Kupferschlager J, La Fougere C, Dittmann H, et al
    Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflow.
    Nuklearmedizin. 2019 Nov 11. doi: 10.1055/a-1022-4115.
    PubMed     Abstract available


    October 2019
  50. LINDNER O, Burchert W, Buechel R, Schafer WM, et al
    Myocardial Perfusion SPECT 2018 in Germany: Results of the 8th Survey.
    Nuklearmedizin. 2019 Oct 24. doi: 10.1055/a-1023-3960.
    PubMed     Abstract available


  51. HEINZEL A, Mottaghy FM, Brenner W, Marienhagen J, et al
    [The teaching of nuclear medicine in Germany].
    Nuklearmedizin. 2019 Oct 10. doi: 10.1055/a-1011-3481.
    PubMed     Abstract available


    September 2019
  52. ANKRAH AO, Lawal IO, Boshomane TMG, Klein HC, et al
    Comparison of Fluorine(18)-fluorodeoxyglucose and Gallium(68)-citrate PET/CT in patients with tuberculosis.
    Nuklearmedizin. 2019 Sep 4. doi: 10.1055/a-1000-6951.
    PubMed     Abstract available


    August 2019
  53. LEONHAUSER B, Happel C, Groner D, Bockisch B, et al
    [Evaluation of intratherapeutic 177Lu-HA-DOTATATE treatment in neuroendocrine tumors: dosimetry with SPECT, whole-body imaging and gamma probe].
    Nuklearmedizin. 2019 Aug 28. doi: 10.1055/a-0987-9689.
    PubMed     Abstract available


  54. HOBERUCK S, Michler E, Wunderlich G, Lock S, et al
    68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patients.
    Nuklearmedizin. 2019 Aug 23. doi: 10.1055/a-0990-8898.
    PubMed     Abstract available


  55. GUHNE F, Drescher R, Seifert P, Freesmeyer M, et al
    Minimal-activity PET/CT for efficacy control after SIRT (MAPECSI) - clinical implementation of a resource-saving, liver-focused protocol.
    Nuklearmedizin. 2019 Aug 14. doi: 10.1055/a-0985-3954.
    PubMed     Abstract available


    July 2019
  56. MICHLER E, Hoberuck S, Martino F, Platzek I, et al
    Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI.
    Nuklearmedizin. 2019 Jul 25. doi: 10.1055/a-0972-0698.
    PubMed     Abstract available


    June 2019
  57. SABET A, Ries M, Al-Khalaf Y, Meyer C, et al
    Early metabolic response assessment of breast cancer liver metastases: 4-week posttreatment FDG PET predicts survival after 90Y microsphere radioembolization.
    Nuklearmedizin. 2019;58:242-248.
    PubMed     Abstract available


  58. KIRCHER M, Seifert S, Kircher S, Lapa C, et al
    [99mTc]Tilmanocept Lymphscintigraphy after inconclusive [99mTc]Nanocolloid Scan in Breast Cancer.
    Nuklearmedizin. 2019;58:282-284.
    PubMed     Abstract available


  59. VERBURG FA, Schmidt M, Kreissl MC, Grunwald F, et al
    [Procedural guideline for Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (version 5)].
    Nuklearmedizin. 2019;58:228-241.
    PubMed     Abstract available


  60. SCHNEIDER C, Dietlein M, Faust M, Drzezga A, et al
    Thyroid hemiagenesis is combined with a variety of thyroid disorders.
    Nuklearmedizin. 2019;58:265-271.
    PubMed     Abstract available


  61. MICHALSKI K, Kurz P, Fuellgraf H, Pfeiffer J, et al
    TTF-1 positive atypical carcinoid of the epiglottis mimicking medullary thyroid carcinoma.
    Nuklearmedizin. 2019;58:279-281.
    PubMed    


    May 2019
  62. FECH V, Alberts I, Rominger A, Afshar-Oromieh A, et al
    PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomography.
    Nuklearmedizin. 2019 May 13. doi: 10.1055/a-0895-5078.
    PubMed     Abstract available


  63. SCHENKE S, Klett R, Acker P, Rink T, et al
    Interobserver Agreement of Planar and SPECT Tc99m-MIBI Scintigraphy for the Assessment of Hypofunctioning Thyroid Nodules.
    Nuklearmedizin. 2019 May 10. doi: 10.1055/a-0894-4843.
    PubMed     Abstract available


    April 2019
  64. YI C, Shi X, Yu D, Luo G, et al
    The combination of 13N-ammonia and 18F-FDG PET/CT in the identification of metabolic phenotype of primary human brain tumors.
    Nuklearmedizin. 2019 Apr 17. doi: 10.1055/a-0835-5746.
    PubMed     Abstract available


    March 2019
  65. KOHLER A, Lock S, Appold S, Bandurska-Luque A, et al
    Comparison of subjective evaluation versus objective algorithm in the interpretation of follow-up FDG-PET/CT scans after radiochemotherapy in head and neck cancer patients.
    Nuklearmedizin. 2019;58:93-100.
    PubMed     Abstract available


  66. ZIPPEL C, Neels OC, Hennrich U, Giesel FL, et al
    [Initiation of clinical multicentre studies with local radiotracer production - Regulatory environment and radiopharmaceutical-organisational aspects].
    Nuklearmedizin. 2019;58:77-85.
    PubMed     Abstract available


    February 2019
  67. UMUTLU L, Beyer T, Grueneisen JS, Rischpler C, et al
    Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.
    Nuklearmedizin. 2019 Feb 28. doi: 10.1055/a-0830-4453.
    PubMed     Abstract available


  68. HUANG EL, Steffen IG, Lukas M, Huang K, et al
    Normal Values for Parotid Gland and Submandibular-Sublingual Salivary Gland Complex Uptake of 99mTechnetium Pertechnetate using SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.
    Nuklearmedizin. 2019;58:39-49.
    PubMed     Abstract available


  69. CERNY M, Dunet V, Rebecchini C, Hahnloser D, et al
    Response of locally advanced rectal cancer (LARC) to radiochemotherapy: DW-MRI and multiparametric PET/CT in correlation with histopathology.
    Nuklearmedizin. 2019;58:28-38.
    PubMed     Abstract available


  70. VERBURG FA, Wiessmann M, Neuloh G, Mottaghy FM, et al
    Intraindividual comparison of selective intraarterial versus systemic intravenous 68Ga-DOTATATE PET/CT in patients with inoperable meningioma.
    Nuklearmedizin. 2019;58:23-27.
    PubMed     Abstract available


  71. CEGLA P, Urbanski B, Burchardt E, Roszak A, et al
    Influence of 18F-FDG-PET/CT on staging of cervical cancer.
    Nuklearmedizin. 2019;58:17-22.
    PubMed     Abstract available


  72. TATSCH K, Buchert R, Bartenstein P, Barthel H, et al
    [Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)].
    Nuklearmedizin. 2019;58:5-16.
    PubMed     Abstract available


    December 2018
  73. FREESMEYER M, Weigand W, Weisheit T
    Examination of the complexation ability of different calixarene derivatives towards [223Ra]RaCl2 in a hospital radiopharmaceutical laboratory.
    Nuklearmedizin. 2018;57:242-246.
    PubMed     Abstract available


  74. LEI J, Yu P, Xu B, Wang R, et al
    Worldwide research productivity in nuclear medicine literature.
    Nuklearmedizin. 2018;57:234-241.
    PubMed     Abstract available


  75. HUANG K, Lukas M, Steffen IG, Lange C, et al
    Normal Values of Renal Function measured with 99mTechnetium Mercaptoacetyltriglycine SPECT in Mice with Respect to Age, Sex and Circadian Rhythm.
    Nuklearmedizin. 2018;57:224-233.
    PubMed     Abstract available


  76. QIAN X, Wenqi Z, Shi G, Bin C, et al
    Indeterminate solitary vertebral lesions on planar scintigraphy.
    Nuklearmedizin. 2018;57:216-223.
    PubMed     Abstract available


  77. LEI J, Yu P, Xu B, Wang R, et al
    Correction: Worldwide research productivity in nuclear medicine literature.
    Nuklearmedizin. 2018;57:E1.
    PubMed    


  78. GRUNWALD L, Derwahl KM, Steinmuller T, Kuwert T, et al

    Nuklearmedizin. 2018;57:N55-N56.
    PubMed    




  79. Nuklearmedizin. 2018;57:XIV.
    PubMed    


  80. SAILER R, Wienke A

    Nuklearmedizin. 2018;57:IX-X.
    PubMed    


  81. WIENKE A, Friese K

    Nuklearmedizin. 2018;57:VI-VIII.
    PubMed    


    September 2018
  82. BOUTER Y, Meller B, Sahlmann CO, Wolf BJ, et al
    Immunohistochemical detection of chemokine receptor 4 expression in chronic osteomyelitis confirms specific uptake in 68Ga-Pentixafor-PET/CT.
    Nuklearmedizin. 2018;57:198-203.
    PubMed     Abstract available


  83. LAWAL IO, Ankrah AO, Mokoala KMG, Popoola GO, et al
    Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection.
    Nuklearmedizin. 2018;57:190-197.
    PubMed     Abstract available


  84. BEINDORFF N, Bartelheimer A, Huang K, Lukas M, et al
    Normal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.
    Nuklearmedizin. 2018;57:181-189.
    PubMed     Abstract available


  85. LIMA GM, Bonfiglioli R, Matti A, Fanti S, et al
    Fluoride PET/CT in Metastatic Benign Pulmonary Calcification.
    Nuklearmedizin. 2018;57:N50-N51.
    PubMed    




  86. Nuklearmedizin. 2018;57:N53.
    PubMed    


    August 2018
  87. GROSSER OS, Ruf J, Kupitz D, Czuczwara D, et al
    Image Quality Assessment for Low-Dose-CT in Hybrid SPECT/CT Imaging.
    Nuklearmedizin. 2018;57:153-159.
    PubMed     Abstract available


  88. VERBURG FA, Grunwald F, Lassmann M, Hanscheid H, et al
    [Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma].
    Nuklearmedizin. 2018;57:124-136.
    PubMed     Abstract available


  89. LINDNER O, Bauersachs J, Bengel FM, Burchert W, et al
    [Policy paper nuclear cardiology - update 2018 - Current status of clinical practice].
    Nuklearmedizin. 2018;57:146-152.
    PubMed     Abstract available




  90. Nuklearmedizin. 2018;57:N33-N49.
    PubMed    


    June 2018
  91. CHOI BW, Won Kim H, Jeon JC, Kang S, et al
    Nodular fasciitis mimicking malignant soft tissue tumor in an infant, with 18F-FDG PET/CT findings: A case report.
    Nuklearmedizin. 2018;57:N29-N31.
    PubMed    


  92. STANZEL S, Pernthaler B, Schwarz T, Bjelic-Radisic V, et al
    Diagnostic and prognostic value of additional SPECT/CT in sentinel lymph node mapping in breast cancer patients.
    Nuklearmedizin. 2018;57:92-99.
    PubMed     Abstract available


  93. KOTZERKE J, Bohmer D, Schlomm T, Maurer T, et al
    [PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection].
    Nuklearmedizin. 2018;57:69-73.
    PubMed     Abstract available


  94. BRAUNE A, Scharffenberg M, Naumann A, Bluth T, et al
    Comparison of 68Ga- and fluorescence-labeled microspheres for measurement of relative pulmonary perfusion in anesthetized pigs.
    Nuklearmedizin. 2018;57:100-107.
    PubMed     Abstract available


  95. SCHUMICHEN C, Schmidt M, Krause T
    [Lung scintigraphy].
    Nuklearmedizin. 2018;57:74-91.
    PubMed     Abstract available




  96. Nuklearmedizin. 2018;57:N32.
    PubMed    


  97. KRAUSE BJ

    Nuklearmedizin. 2018;57:66-67.
    PubMed    


    April 2018
  98. SCHOEN M, Braun T, Manava P, Ludwigs S, et al
    Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
    Nuklearmedizin. 2018;57:50-55.
    PubMed     Abstract available




  99. Nuklearmedizin. 2018;57:N14-N27.
    PubMed    


  100. BRENNER W

    Nuklearmedizin. 2018;57:N9.
    PubMed    


    February 2018
  101. SCHAEFER WM, Knollmann D, Avondo J, Meyer A, et al
    Volume/perfusion ratio from lung SPECT/CT.
    Nuklearmedizin. 2018;57:31-34.
    PubMed     Abstract available


  102. DRAGER DL, Heuschkel M, Protzel C, Erbersdobler A, et al
    [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
    Nuklearmedizin. 2018;57:26-30.
    PubMed     Abstract available


  103. BOY C, Poeppel T, Kotzerke J, Krause BJ, et al
    [Somatostatin receptor PET/CT (SSTR-PET/CT)].
    Nuklearmedizin. 2018;57:4-17.
    PubMed     Abstract available


  104. ROGASCH JMM, Amthauer H, Furth C, Hundsdoerfer P, et al
    I-123-MIBG scintigraphy in patients with neuroblastoma.
    Nuklearmedizin. 2018;57:35-39.
    PubMed     Abstract available


  105. FILSS C, Heinzel A, Miiller B, Vogg ATJ, et al
    Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy.
    Nuklearmedizin. 2018;57:19-25.
    PubMed     Abstract available


  106. COENEN HH, Gee AD, Adam M, Antoni G, et al
    International Consensus Radiochemistry Nomenclature Guidelines.
    Nuklearmedizin. 2018;57:40-41.
    PubMed    




  107. Nuklearmedizin. 2018;57:18.
    PubMed    


  108. BURCHERT W

    Nuklearmedizin. 2018;57:N6-N8.
    PubMed    


  109. PICHLER B

    Nuklearmedizin. 2018;57:N5.
    PubMed    




  110. Nuklearmedizin. 2018;57:N5.
    PubMed    




  111. Nuklearmedizin. 2018;57:N4.
    PubMed    


  112. RISCHPLER C, Schwamborn K, Schwaiger M, Maurer T, et al
    Radio-guided-surgery of a paravertebral paraganglioma using I-123-MIBG.
    Nuklearmedizin. 2018;57:N2-N3.
    PubMed    


    July 2017
  113. ZHANG Y, Li B, Shi H, Yu H, et al
    Added value of SPECT/spiral CT versus SPECT or CT alone in diagnosing solitary skeletal lesions.
    Nuklearmedizin. 2017;56.
    PubMed     Abstract available


    June 2017
  114. LINDNER O, Bengel F, Burchert W, Dorr R, et al
    [Myokard-Perfusions-SPECT. Myocardial perfusion SPECT - Update S1 guideline].
    Nuklearmedizin. 2017;56.
    PubMed     Abstract available


    May 2017
  115. LEE JW, Park JS, Park KB, Yoo GH, et al
    Prediction of renal cortical defect and scar using neutrophil-to-lymphocyte ratio in children with febrile urinary tract infection.
    Nuklearmedizin. 2017 May 10. doi: 10.3413/Nukmed-0878.
    PubMed     Abstract available


    April 2017
  116. LUTJE S, Cohnen J, Gomez B, Gruneisen J, et al
    Integrated 68Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancer.
    Nuklearmedizin. 2017 Apr 12. doi: 10.3413/Nukmed-0850.
    PubMed     Abstract available


    December 2016
  117. ILHAN H, Mustafa M, Bartenstein P, Kuwert T, et al
    Rate of elimination of radioiodine-avid lymph node metastases of differentiated thyroid carcinoma by postsurgical radioiodine ablation. A bicentric study.
    Nuklearmedizin. 2016;55:221-227.
    PubMed     Abstract available


    September 2016
  118. POPPEL TD, Andreeff M, Becherer A, Bockisch A, et al
    [Therapy of bone metastases with radium-223. German guidelines].
    Nuklearmedizin. 2016;55:177-86.
    PubMed     Abstract available


    August 2016
  119. LI B, Zhang M, Jin J
    Unusual FDG uptakes of mesenteric brown adipose tissue in a patient with pheochromocytomas.
    Nuklearmedizin. 2016;55:N32-3.
    PubMed    


  120. SCHUTZE C, Knoop BO, Vehrenkamp I, Rudolf F, et al
    [Constancy check of system linearity for dose calibrators. Effect of molybdenum impurities at high start activities of 99mTc].
    Nuklearmedizin. 2016;55:172-5.
    PubMed     Abstract available


  121. KIM SJ, Choi JY, Lee JH, Hyun SH, et al
    Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.
    Nuklearmedizin. 2016;55:166-71.
    PubMed     Abstract available


    June 2016
  122. FENDLER WP, Kratochwil C, Ahmadzadehfar H, Rahbar K, et al
    [177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer].
    Nuklearmedizin. 2016;55:123-8.
    PubMed     Abstract available


  123. DIETLEIN M, Eschner W, Grunwald F, Lassmann M, et al
    [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
    Nuklearmedizin. 2016;55:77-89.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: